A carregar...
Rapamycin impairs HPD-induced beneficial effects on glucose homeostasis
BACKGROUND AND PURPOSE: Rapamycin, which is used clinically to treat graft rejection, has also been proposed to have an effect on metabolic syndrome; however, very little information is available on its effects in lean animals/humans. The purpose of this study was to characterize further the effects...
Na minha lista:
| Publicado no: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4523336/ https://ncbi.nlm.nih.gov/pubmed/25884889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13168 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|